Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey
Rossella E. Nappi, Emad Siddiqui, Lora Todorova, et al.
Maturitas (2022) Vol. 167, pp. 66-74
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Stress, depression, and anxiety: psychological complaints across menopausal stages
Ming Jun Kuck, Eef Hogervorst
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 10
Real-world clinical evaluation of natural and induced vasomotor symptoms in the USA and Europe
Sheryl A. Kingsberg, Victoria Banks, Cecilia Caetano, et al.
Climacteric (2024) Vol. 27, Iss. 4, pp. 364-372
Open Access | Times Cited: 8
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial
Katrin Schaudig, Xuegong Wang, Céline Bouchard, et al.
BMJ (2024), pp. e079525-e079525
Open Access | Times Cited: 6
Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: Findings from the REALISE study
Sheryl A. Kingsberg, Victoria Banks, Cecilia Caetano, et al.
Maturitas (2024) Vol. 189, pp. 108096-108096
Open Access | Times Cited: 5
Does everyday discrimination account for the increased risk of vasomotor symptoms in Black women?: the Study of Women's Health Across the Nation (SWAN)
Alexis N. Reeves, Tené T. Lewis, Michelle M. Hood, et al.
Menopause The Journal of The North American Menopause Society (2024) Vol. 31, Iss. 6, pp. 484-493
Closed Access | Times Cited: 4
Elinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms
Marlene Hager, Tal Goldstein, Victoria W. Fitz, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 783-789
Open Access | Times Cited: 4
The Impact of Estrogen Deficiency Symptoms on Health-Related Quality of Life in Menopausal-Aged Women in China
Martin Downes, Kyoo il Kim, M. Custodio, et al.
IntechOpen eBooks (2025)
Closed Access
Clinical Symptoms and Quality of Life: Vasomotor Symptoms and Mood
Plácido Llaneza, Cristina Llaneza-Suárez
(2025), pp. 75-87
Closed Access
Cardiovascular risk management in women in peri- and postmenopause: a global health challenge (literature review)
O. A. Minyailo, O.A. Melkozerova, Yu. A. Semenov, et al.
Vestnik ohrany materinstva i mladenčestva. (2025) Vol. 2, Iss. 1, pp. 10-20
Closed Access
Prevalence and impact of vasomotor symptoms associated with menopause among Nordic women: Subgroup analysis from an international cross‐sectional survey
Angelica Lindén Hirschberg, Päivi Polo‐Kantola, Inger Øverlie, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2025)
Open Access
Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy
Fatima Hassan, Anam Saleem, Sehar Saba Samuel, et al.
Medicine (2023) Vol. 102, Iss. 23, pp. e33978-e33978
Open Access | Times Cited: 9
Nonhormonal Pharmacotherapies for the Treatment of Postmenopausal Vasomotor Symptoms
Taylor Witten, J Staszkiewicz, Logan Gold, et al.
Cureus (2024)
Open Access | Times Cited: 3
Retrospective text and qualitative analyses of patient experience and management of vasomotor symptoms due to menopause: voices from the PatientsLikeMe community
Jessica A. Shepherd, Aki Shiozawa, Arianne L. Schild, et al.
Menopause The Journal of The North American Menopause Society (2024) Vol. 31, Iss. 9, pp. 789-795
Open Access | Times Cited: 3
Treatment utilization and non-drug interventions for vasomotor symptoms in breast cancer survivors taking endocrine therapy: Real-world findings from the United States and Europe
Sheryl A. Kingsberg, Victoria Banks, Cecilia Caetano, et al.
Maturitas (2024) Vol. 188, pp. 108071-108071
Closed Access | Times Cited: 3
Effectiveness of Yoga on Menopausal Symptoms and Quality of life among Menopausal women: A Systematic Review
Shobana Gangadharan, Judie Arulappan, Gerald Amandu Matua, et al.
International journal of Nutrition Pharmacology Neurological Diseases (2024) Vol. 14, Iss. 3, pp. 300-316
Closed Access | Times Cited: 2
General self-efficacy as a moderator between severity of menopausal symptoms and satisfaction with life in menopausal women
Agnieszka Bień, Iwona Niewiadomska, Magdalena Korżyńska‐Piętas, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Physician–patient alignment on menopause-associated symptom burden: real-world evidence from the USA and Europe
Sheryl A. Kingsberg, Rossella E. Nappi, Megan Scott, et al.
Climacteric (2024), pp. 1-8
Open Access | Times Cited: 2
Menopausal Status Impact on the Quality of Life in Kazakhstani Healthcare Workers: A Cross-sectional Study
Sanja Terzic, Gauri Bapayeva, Nazira Kadroldinova, et al.
Journal of General Internal Medicine (2024) Vol. 39, Iss. 6, pp. 969-977
Closed Access | Times Cited: 1
Ultra-low-dose continuous combined estradiol and dydrogesterone in postmenopausal women: A pooled safety and tolerability analysis
Т. Ф Татарчук, John C. Stevenson, Yu Qi, et al.
Gynecological Endocrinology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 1
The effect of 17β-estradiol plus norethisterone acetate on blood pressure and inflammation markers: A meta-analysis of randomized controlled trials
Hong Liu, Zhan Jiang, Jiao He, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2023) Vol. 285, pp. 59-68
Closed Access | Times Cited: 2
The flash dance of midlife: the Skylight 1 trial
Andrea Z. LaCroix, Kristine E. Ensrud
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1324-1325
Closed Access | Times Cited: 2
The COVID-19 Pandemic Impact on the Psychophysical Health of Post-Menopausal Women: A Cross-Sectional Study
Alessandra Lami, Giulia Giacomelli, Jacopo Lenzi, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1154-1154
Open Access | Times Cited: 2
In silico guided in vitro study of traditionally used medicinal plants reveal the alleviation of post-menopausal symptoms through ERβ binding and MAO-A inhibition
Poonam Rawat, Bhanu Kumar, Ankita Misra, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-14
Closed Access | Times Cited: 2
Menopause as a window of opportunity: the benefits of designing more effective theory-driven behaviour change interventions to promote healthier lifestyle choices at midlife
E. Simpson, Julie Doherty, Deirdre Timlin
Proceedings of The Nutrition Society (2023) Vol. 83, Iss. 2, pp. 120-129
Open Access | Times Cited: 2
Is it time to rethink how menopause is defined?
Lauren Streicher
Menopause The Journal of The North American Menopause Society (2023) Vol. 30, Iss. 12, pp. 1177-1178
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top